(A) Schematic overview of the nuclear morphology screen to identify genes required for proper nuclear shape and size. Cells were cultured in the presence of siRNAs targeting specific genes in …
(A) The initial screen was performed in two biological replicates on different days. Nuclear shape Z-scores of the two replicates (Replicate 1 and Replicate 2) of the nuclear shape screen. …
Independent Z-scores for nuclear size or nuclear shape were generated first by measuring nuclear circularity or area, respectively. Nuclear shape was measured by calculating circularity (circularity …
(A) Z-scores of the top nuclear shape determinants which had low cell number. Error bars indicate the standard deviation. (B) Montage of nuclear shape determinants with low cell number revealed …
(A) Nuclear shape hits were calculated by scoring circularity (circularity = 4πArea/perimeter2). Z-scores were generated to compare hits across the screen. Error bars indicate the standard …
(A–J) Frequency distribution of nuclear shape in cells treated with scrambled control or indicated siRNA. siRNA-treated samples generally show a shift of the entire distribution rather than loss or …
(A) A diagram of the relationship between circularity used to calculate nuclear shape and nuclear perimeter and area revealing the possibility that nuclear size might affect nuclear shape. Nuclear …
(A) The fibroblast screen was performed in two biological replicates on different days. Lamin A/C expression Z-scores compared to nuclear size Z-scores in human fibroblast cells. Spearman’s …
(A) Little overlap of hits for nuclear shape changes in immortalized human fibroblast cells compared to nuclear shape hits for the breast epithelial cell line MCF10AT. The MCF10AT screen was …
Nuclear shape changes were measured by calculating mean circularity values on a per well basis. (A–J) Cells were treated with single siRNAs to the indicated target previously identified nuclear …
(A–H) Knockdown efficiency of indicated target gene in fibroblast and MCF10AT cells treated with a single siRNA. Error bars indicate standard deviation.
(A) The MCF10AT screen was performed in two biological replicates on different days. Representation of normal nuclei and hits with enlarged nuclei identified by high-throughput screening in MCF10AT …
(A) The MCF10AT screen was performed in two biological replicates on different days. Lamin A/C expression Z-scores compared to lamin B1 Z-scores in MCF10AT cells. Spearman’s coefficient (r=0.8903). …
(A) The MCF10AT screen was performed in two biological replicates on different days. Representation of normal nuclei and nuclear shape hits identified by high-throughput screening in MCF10AT cells. …
(A) A diagram of constructs used in binding assays. All histone pulldown assays were performed at least three times. (B) Colloidal staining of purified recombinant proteins and histone pulldown …
Source data for Figure 4B.
Source data for Figure 4C.
Source data for Figure 4D.
(A) Diagram of mature lamin A and progerin constructs used in the binding assays. All histone pulldown assays were performed at least three times. (B) GST pulldown assay with wild-type GST-lamin A …
Source data for Figure 4—figure supplement 1B.
Source data for Figure 4—figure supplement 1C.
Source data for Figure 4—figure supplement 1D.
Source data for Figure 4—figure supplement 1E.
(A) In vitro peptide binding array assay using GST-lamin A (506–646). Intensity of signal indicates binding. The peptide binding assay was performed three times. (B) Peptide binding assays for …
(A) Wild-type (WT) and mutant histone expression constructs . Mutant histone expression experiments were performed with three biological replicates. (B) Stable expression of indicated H3.3 mutants …
Correlation plot of total histone H3.3 expression relative to (A) V5 alone, (B) wild-type H3.3-V5, (C) H3.3K9M-V5 expression, (D) H3.3K27M-V5 expression, (E) H3.3K36M-V5 expression. Values …
(A) Cells expressing wild-type histone H3.1, H3.1K9M, or H3.1K27M mutants showed little change in nuclear shape scores. The mean is indicated by the horizontal line. Mutant histone expression …
Correlation plot of nuclear shape scores relative to (A) wild-type H3.3-V5 expression, (B) H3.3K9M-V5 expression, (C) H3.3K27M-V5 expression, (D) H3.3K36M-V5 expression. Values determined by …
Correlation plot of lamin A/C expression relative to (A) wild-type H3.3-V5, (B) H3.3K9M-V5 expression, (C) H3.3K27M-V5 expression, (D) H3.3K36M-V5 expression. Values determined by quantitative …
Correlation plot of nuclear size values relative to nuclear shape values in cells expressing (A) V5 alone, (B) wild-type H3.3-V5, (C) H3.3K9M-V5, (D) H3.3K27M-V5, (E) H3.3K36M-V5. Values determined …
High-throughput screening targets and hits.
(A) lists the genes targeted in the screen. (B) is a file describing the plasmids generated during this study. (C) lists the antibodies used in this study. (D) is a comparative list of nuclear shape Z-score, nuclear shape raw score, nuclear area, and nuclear perimeter measurements.
Nuclear shape hits.
(A) lists hits altering nuclear shape in fibroblast cells. (B) is a list of hits resulting in lower lamin A/C expression. (C) is a list of hits resulting in lowered lamin B1 expression.
Screen validation.
(A) lists validation results for the nuclear shape screen in fibroblast cells. (B) lists validation results for hits increasing nuclear size in fibroblast cells. (C) lists validation results for hits decreasing nuclear size in fibroblast cells. (D) identifies nuclear shape hits in MCF10AT cells. (E) lists lamin A interacting peptides.